GlaxoSmithKline in China (B) (Spanish version)
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later, GSK's CEO, Andrew Witty, called the allegations "shameful" and said the company would use the opportunity to "make changes."
Collection: HBSP (USA)
Ref: HBS-514S20
Format: PDF
Number of pages: 4
Publication Date: Jun 18, 2014
Language: Spanish
Review date: Sep 8, 2015
What material is included in this case:
Description
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later, GSK's CEO, Andrew Witty, called the allegations "shameful" and said the company would use the opportunity to "make changes."
Read more
Year: 2013
Geographic Setting: China;United Kingdom;United States
Industry Setting: Apparel accessories; Healthcare sector; Healthcare service industry; Insurance industry; Pharmaceutical industry
Leave your rating
"GlaxoSmithKline in China (B) (Spanish version)"
Register for free with IESE Publishing and enjoy all the advantages
What type of account do you want to create?
Choose account type
Professors
Academic Institutions
Companies
Individuals